Marek Rżewski, MD

Vice President of International Sales at Zytovision GmbH
  • Claim this Profile
Contact Information
Location
Madrid, Community of Madrid, Spain, ES
Languages
  • English Full professional proficiency
  • Polish Native or bilingual proficiency
  • German Limited working proficiency
  • Spanish Professional working proficiency
  • Russian Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Karin Dahllöf

I met Marek when we were both working for HemoCue. He is extremely intelligent, articulate & persuasive but what I personally appreciate most is his straightforwardness and honesty in his professional opinions and business relationships. Marek’s passion, drive & loyalty make him an invaluable asset to any organization and I'm happy I got the chance to work with him.

Andrzej Urban

Marek is business oriented. I recomend him.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Vice President of International Sales
      • Jun 2021 - Present

      ZytoMax GmbH holding leadership team member, full responsibility for international sales at ZytoVision. Focus on US and EU markets ZytoMax was created from the acquisition of three companies Zytomed Systems GmbH, ZytoVision GmbH and 42 Life Sciences GmbH & Co KG. The Group is a fully integrated developer, manufacturer, and distributor of in-situ hybridization (ISH) and immunohistochemistry (IHC) cancer diagnostics tests and equipment for clinical pathology labs in hospitals and private practices. The combined companies offer over 40,000 products. Show less

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Vice President of International Sales
      • Jun 2021 - Present

      ZytoMax GmbH holding leadership team member, full responsibility for international sales ZytoMax GmbH holding leadership team member, full responsibility for international sales

    • Spain
    • Business Consulting and Services
    • Commercial Freelancer, Diagnostics (IVD) / Medical Devices / Aesthetic Medicine
      • May 2019 - Present

      Strategic and ‘hands on’ experience with a focus on the European IVD and medical device market. Strategic and ‘hands on’ experience with a focus on the European IVD and medical device market.

    • Poland
    • Personal Care Product Manufacturing
    • 1 - 100 Employee
    • Director, Go-to-Market Strategy and International Sales / Aesthetic Medicine (part time)
      • Feb 2020 - Jan 2021

      DermoTech Beauty is an innovative cosmetic company focused on the professional solutions adressed to aestethic medicine professionals. The company patended the production of the most potent antioxidant ever discovered - Xantohumol. Our Xantohumol Complex used in the proXN line is 30 times more active than vitamin C in cosmetic formulations. DermoTech Beauty is an innovative cosmetic company focused on the professional solutions adressed to aestethic medicine professionals. The company patended the production of the most potent antioxidant ever discovered - Xantohumol. Our Xantohumol Complex used in the proXN line is 30 times more active than vitamin C in cosmetic formulations.

    • France
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • International Commercial Director (Interim project)
      • May 2019 - Jan 2020

      Project for scaling a business from a start-up level to the fully functional commercial organisation. Building organisational and go-to-market strategy. Executing sales network development: ⭐ Selection of the new business partners in WE (Germany, Nordics), CEE (Romania, Slovakia) & LATAM (Mexico and Brazil). 🔑 Facilitating business discussions in the regions of APAC and ME About AVALUN: Avalun is a French based START-UP company focused on developing next generation Point-Of-Care testing devices. The first commercialized product is LabPad INR with its initial presence in Europe, MENA and LATAM. Avalun is the spin-off from the CEA-LETI research laboratory in Grenoble. The CEA-LETI lab works mainly on micro/nano technologies and specializes in microsystems, biotech, photonics and nanoelectronics. It is located mainly in Grenoble, France. Show less

    • Sweden
    • Medical Equipment Manufacturing
    • 200 - 300 Employee
    • Regional Sales Director Southern Europe, Russia/CIS, MENA and Brazil
      • Nov 2018 - May 2019

      Products from HemoCue - a Danaher company - are being used in more than 130 countries worldwide.140 Million Tests Carried Out Per Year = 4 Tests Performed Every Second All Year Around.HemoCue is a global leader in the field of point-of-care testing. In 1982 the first system making accurate hemoglobin testing possible in the near-patient setting was introduced. Since then portfolio was developed by adding point-of-care tests for glucose, urine albumin, HbA1c, total and differential white blood cell count.Danaher is a Fortune 500 science and technology innovator helping solve complex challenges, and improving quality of life around the world. Show less

    • Regional Sales Director Europe, Russia/CIS and Turkey
      • Oct 2015 - Nov 2018

      Responsible for business operations in Western Europe, CEE & Russia/CIS region.Mixed structure of direct and indirect sales channels.POCT / Point of care testing : Blood Banks, Primary Care, Hospital

    • Regional Sales Manager Europe
      • Jan 2015 - Oct 2015

      Responsible for European sales operations (WE & CEE) // mixed structure of direct and indirect sales channels.

    • Regional Sales Manager CEE
      • Mar 2013 - Dec 2014

      HemoCue AB develops, produces, and markets medical diagnostic products for Point of Care testing. The fundamental concept behind the HemoCue products is to perform important common blood and urine tests that offer lab quality results at the Point of Care without sacrificing the accuracy and precision offered by a central clinical lab. Responsibility for business operations in Central and Southeastern Europe plus Israel

    • United States
    • Pharmaceutical Manufacturing
    • 200 - 300 Employee
    • Regional General Manager
      • Jan 2012 - Feb 2013

      The Medicines Company is a Novartis CompanyPosition responsibilities: Full P&L responsibility for Central EU cluster operations (sales, marketing, distribution, and market access). Region of Poland, Czech Republic, Slovakia, Slovenia. 24th of November 2019 Novartis announced to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death.

    • General Manager Poland
      • Oct 2010 - Dec 2011

      Full P&L responsibility for Polish Operations.The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences.

    • France
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Medical Manager, Product Manager Diabetes
      • Feb 2008 - Oct 2010

      Product portfolio : insulins - LANTUS, APIDRA, oral antidiabetic drug - AMARYL, medical devices - pens:SoloStar,OptiPen,Opticlick, BGM (blood glucose monitoring systems - glucometers). Product portfolio : insulins - LANTUS, APIDRA, oral antidiabetic drug - AMARYL, medical devices - pens:SoloStar,OptiPen,Opticlick, BGM (blood glucose monitoring systems - glucometers).

    • United States
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Sales and Marketing Manager (Aortic Stent Grafts)
      • Jan 2006 - Jan 2008

      P&L and sales responsibility for the independent company business area – Endovascular Sub-unit.Team management. Cooperation with clinical experts (KOLs) to achieve sales goals. Life-cycle management of existing products as well as introduction of new products.Managing distribution issues. Products portfolio: Endovascular Medical Devices: TALENT, VALIANT(Stent-Graft Systems) P&L and sales responsibility for the independent company business area – Endovascular Sub-unit.Team management. Cooperation with clinical experts (KOLs) to achieve sales goals. Life-cycle management of existing products as well as introduction of new products.Managing distribution issues. Products portfolio: Endovascular Medical Devices: TALENT, VALIANT(Stent-Graft Systems)

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Medical Representative, Regional Manager
      • Feb 2005 - Jan 2006

      Products portfolio: Branded Medicines – Cardiology, Diabetes, Metabolic Diseases Products portfolio: Branded Medicines – Cardiology, Diabetes, Metabolic Diseases

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Medical Representative
      • Mar 2004 - Feb 2005

      Product portfolio: Branded medicines – Cardiology, Infectious Diseases, Obesity (sibutramine). Product portfolio: Branded medicines – Cardiology, Infectious Diseases, Obesity (sibutramine).

Education

  • Medical University of Lodz, Studies in English
    Medical Doctor, Medicine
    1996 - 2002
  • University of Lodz
    Master Degree, Economics
    2001 - 2007
  • The London School of Economics and Political Science (LSE)
    Leadership course: Current approaches to leadership and applications to professional development
    2011 - 2011

Community

You need to have a working account to view this content. Click here to join now